Study design (if review, criteria of inclusion for studies)
Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Participants
Cystic Fibrosis - 18 Years and older (Adult, Older Adult)
Interventions
Drug: Standard Dose YPT-01|Drug: High Dose YPT-01|Other: Placebo
Outcome measures
Reduction in sputum bacterial culture|Change in lung function|Change in the rate of pulmonary exacerbations|Change in the rate of hospitalization|Change in the rate of acute antibiotic use|Patient's Quality of Life
Related topics
Antibiotic treatment for stenotrophomonas maltophilia in people with cystic fibrosis
Antibiotic treatment of early pseudomonas aeruginosa
Antibiotics for pulmonary exacerbations
Inhaled antibiotics in cystic fibrosis
Prophylactic use of oral antistaphylococcal antibiotic
Scheduled antibiotics every 3-4 months / symptom-based treatment